Skip to content
Menu
About
About CIRN
Governance
Partners
Our Network
Networks
Members
Institutions
Champions
Research
Studies
Publications
Resources
Get Involved
Membership
Training & Education
AGM 2026
News & Events
Map
Contact
À propos
À propos du RCRI
Gouvernance
Partenaires
Notre réseau
Réseaux
Membres
Institutions
Champions
Recherche
Études
Publications
Ressources
Participer
Adhésion
Formation
AGA 2026
Actualités et événements
Carte
Contact
EN
FR
Home
Accueil
/
Publications
Publications
/
Publication
Publication
Incorporation of health economic evaluation into immunization policy-making in Canada: Barriers and facilitators
Incorporation of health economic evaluation into immunization policy-making in Canada: Barriers and facilitators
Vaccine · 2020 · Journal Article
Vaccine · 2020 · Journal Article
Read on doi.org
Lire sur doi.org
Members
Membres
Joanne Langley
Joanne Langley
Principal Investigator
Investigateur·rice principal·e
Dalhousie University · Halifax, NS
Dalhousie University · Halifax, NS
View profile
Voir le profil
Authors
Auteurs
Hester A. Hopman · Natasha S. Crowcroft · Tomris Cesuroglu · Joanne M. Langley
Related Publications
Publications associées
Parental acceptability of new RSV preventive therapies for infants: A cross-sectional survey in Canada
Parental acceptability of new RSV preventive therapies for infants: A cross-sectional survey in Canada
Human Vaccines & Immunotherapeutics · 2026
Human Vaccines & Immunotherapeutics · 2026
View publication
Voir la publication
Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis
Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis
BMC Infectious Diseases · 2025
BMC Infectious Diseases · 2025
View publication
Voir la publication
Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: a systematic review and meta-analysis
Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: a systematic review and meta-analysis
The Lancet Child & Adolescent Health · 2025
The Lancet Child & Adolescent Health · 2025
View publication
Voir la publication
Impact and cost-effectiveness analyses of vaccination for prevention of respiratory syncytial virus disease among older adults in Ontario: A Canadian Immunization Research Network (CIRN) study
Impact and cost-effectiveness analyses of vaccination for prevention of respiratory syncytial virus disease among older adults in Ontario: A Canadian Immunization Research Network (CIRN) study
Vaccine · 2024
Vaccine · 2024
View publication
Voir la publication
Safety and immunogenicity of a delayed booster dose of the rVSVΔG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial
Safety and immunogenicity of a delayed booster dose of the rVSVΔG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial
The Lancet Microbe · 2024
The Lancet Microbe · 2024
View publication
Voir la publication
Leveraging Influenza Virus Surveillance From 2012 to 2015 to Characterize the Burden of Respiratory Syncytial Virus Disease in Canadian Adults ≥50 Years of Age Hospitalized With Acute Respiratory Illness
Leveraging Influenza Virus Surveillance From 2012 to 2015 to Characterize the Burden of Respiratory Syncytial Virus Disease in Canadian Adults ≥50 Years of Age Hospitalized With Acute Respiratory Illness
Open Forum Infectious Diseases · 2023
Open Forum Infectious Diseases · 2023
View publication
Voir la publication